FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q92182785> ?p ?o ?g. }

• Q92182785 description "article scientifique publié en 2019" @default.
• Q92182785 description "artículu científicu espublizáu en xunetu de 2019" @default.
• Q92182785 description "scientific article published on 22 July 2019" @default.
• Q92182785 description "wetenschappelijk artikel" @default.
• Q92182785 description "наукова стаття, опублікована 22 липня 2019" @default.
• Q92182785 description "գիտական հոդված հրատարակված 2019 թվականի հուլիսի 22-ին" @default.
• Q92182785 name "Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study" @default.
• Q92182785 name "Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study" @default.
• Q92182785 type Item @default.
• Q92182785 label "Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study" @default.
• Q92182785 label "Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study" @default.
• Q92182785 prefLabel "Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study" @default.
• Q92182785 prefLabel "Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study" @default.
• Q92182785 P1433 Q92182785-E180DBA1-7F78-4F29-AE34-280229659DBB @default.
• Q92182785 P1476 Q92182785-F203609B-9781-482F-9DCB-BC033DB661C1 @default.
• Q92182785 P2093 Q92182785-0A5C3AA0-6B7E-4105-BFF4-112143A1D51D @default.
• Q92182785 P2093 Q92182785-24A58CE7-D497-46F5-BF44-E2047F48033F @default.
• Q92182785 P2093 Q92182785-2AC3A4D2-B6F6-4492-973C-A7D307003775 @default.
• Q92182785 P2093 Q92182785-38D371B3-319D-485A-8F0C-0C247315729C @default.
• Q92182785 P2093 Q92182785-8425277E-9068-43C3-8116-FFF2A8431048 @default.
• Q92182785 P2093 Q92182785-98DD6AA2-0937-47CC-BF46-88B40AC04CDE @default.
• Q92182785 P2093 Q92182785-ABFABC82-C98D-4F36-90A6-1EEF7E79B4B1 @default.
• Q92182785 P2093 Q92182785-BA92AFB5-65EA-4A0A-8756-377F13FFD164 @default.
• Q92182785 P2093 Q92182785-C039F333-06CB-435A-A7D8-337A7A949F0D @default.
• Q92182785 P2093 Q92182785-C3FA4AE7-7D87-48FC-BA25-203A6858C8AC @default.
• Q92182785 P2093 Q92182785-C74C5F2A-656D-4E52-A7A0-9825B16D69DC @default.
• Q92182785 P2093 Q92182785-CDBC4DDB-86CF-4A00-8507-4BECDD495399 @default.
• Q92182785 P2093 Q92182785-D05A5050-01A9-428A-BD97-F60A42519976 @default.
• Q92182785 P2093 Q92182785-F99F24C9-1515-4C8B-9BC2-B722ACFDEFAF @default.
• Q92182785 P2860 Q92182785-013B3C0F-EF5D-43F9-93EF-3376D70BBFBB @default.
• Q92182785 P2860 Q92182785-078988D5-EC56-4C37-9D3D-55184E0D7D63 @default.
• Q92182785 P2860 Q92182785-1A3C730B-3A7C-4990-BBB3-D338A27DE21C @default.
• Q92182785 P2860 Q92182785-2DB06D6D-FF34-4853-81E8-E0441A5B276D @default.
• Q92182785 P2860 Q92182785-32EBC75E-01AF-4848-9FD2-25C84E55053F @default.
• Q92182785 P2860 Q92182785-3CCE7D4D-9E16-4CBA-AF2E-06440938E359 @default.
• Q92182785 P2860 Q92182785-5A080A6B-BE22-438D-9D0C-68F36B1DDA2F @default.
• Q92182785 P2860 Q92182785-765012C6-FEBD-4F25-95B9-0FD5CED7E219 @default.
• Q92182785 P2860 Q92182785-87A7267A-C999-4145-9E84-53B7327F5B6D @default.
• Q92182785 P2860 Q92182785-95EB82D1-452D-478C-89BA-5DD920ECB4E3 @default.
• Q92182785 P2860 Q92182785-99E1C07F-1281-432F-9F6B-1563BFA3A9F5 @default.
• Q92182785 P2860 Q92182785-B0832A6E-4A32-4B2F-95FC-55E525443A60 @default.
• Q92182785 P2860 Q92182785-D911BCB5-C2F2-45B7-94BA-D605C0228871 @default.
• Q92182785 P2860 Q92182785-E0CDA005-B2CF-4D8C-8805-52D6B444085E @default.
• Q92182785 P2860 Q92182785-EF9BB1E1-B70D-4FF8-A87D-F685606DAB2C @default.
• Q92182785 P2860 Q92182785-FB059BE4-0C7E-4162-A6A1-A467F9605E90 @default.
• Q92182785 P2860 Q92182785-FE46A3DB-B182-42B5-BDEB-49A304C3ADB6 @default.
• Q92182785 P304 Q92182785-9000B5A7-938D-4B71-9BEF-0F4D317951B8 @default.
• Q92182785 P31 Q92182785-970390B0-44C1-42D5-BA6F-FD3A1C153BB8 @default.
• Q92182785 P356 Q92182785-6F7F7725-0333-4285-8062-0FB7A665BB03 @default.
• Q92182785 P433 Q92182785-3638DEA1-4C0A-445B-8B36-85EE91808862 @default.
• Q92182785 P478 Q92182785-979955DA-4915-4142-AA03-7B56A107C4C9 @default.
• Q92182785 P50 Q92182785-20A0F94A-773D-4879-9569-03BB81021E9F @default.
• Q92182785 P50 Q92182785-2D7E11CD-6DD0-4E17-99DE-73B863ABEC01 @default.
• Q92182785 P50 Q92182785-3074DC5F-CA8A-4200-AF98-5DE557C748D6 @default.
• Q92182785 P50 Q92182785-9B18A867-ECE6-404D-8EDE-0D9009C555D2 @default.
• Q92182785 P50 Q92182785-A81E8F2A-2666-4E53-84F0-98F653FB1236 @default.
• Q92182785 P50 Q92182785-E0741925-1B34-46F3-8D64-57D108E06126 @default.
• Q92182785 P577 Q92182785-119568D6-AFBF-4AF8-872B-E7557E3787F2 @default.
• Q92182785 P698 Q92182785-7664C169-3D8F-4A70-8096-3F593668A590 @default.
• Q92182785 P921 Q92182785-F5E8415B-1925-40C7-8833-F62E61A10B76 @default.
• Q92182785 P356 S1470-2045(19)30388-2 @default.
• Q92182785 P698 31345627 @default.
• Q92182785 P1433 Q13747613 @default.
• Q92182785 P1476 "Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study" @default.
• Q92182785 P2093 "Adil Daud" @default.
• Q92182785 P2093 "Ana Arance" @default.
• Q92182785 P2093 "Caroline Robert" @default.
• Q92182785 P2093 "Catriona M McNeil" @default.
• Q92182785 P2093 "Clemens Krepler" @default.
• Q92182785 P2093 "James M G Larkin" @default.
• Q92182785 P2093 "Jean-Jacques Grob" @default.
• Q92182785 P2093 "Laurent Mortier" @default.
• Q92182785 P2093 "Matteo S Carlino" @default.
• Q92182785 P2093 "Michal Lotem" @default.
• Q92182785 P2093 "Nageatte Ibrahim" @default.
• Q92182785 P2093 "Omid Hamid" @default.
• Q92182785 P2093 "Shu-Chih Su" @default.
• Q92182785 P2093 "Teresa M Petrella" @default.
• Q92182785 P2860 Q27861062 @default.
• Q92182785 P2860 Q28131668 @default.
• Q92182785 P2860 Q29618134 @default.
• Q92182785 P2860 Q30890582 @default.
• Q92182785 P2860 Q35235365 @default.
• Q92182785 P2860 Q36642804 @default.
• Q92182785 P2860 Q38393470 @default.
• Q92182785 P2860 Q38617638 @default.
• Q92182785 P2860 Q41501755 @default.
• Q92182785 P2860 Q46394566 @default.
• Q92182785 P2860 Q47239552 @default.
• Q92182785 P2860 Q47549857 @default.
• Q92182785 P2860 Q54518660 @default.
• Q92182785 P2860 Q54962510 @default.
• Q92182785 P2860 Q58599459 @default.
• Q92182785 P2860 Q64242033 @default.
• Q92182785 P2860 Q88220408 @default.
• Q92182785 P304 "1239-1251" @default.
• Q92182785 P31 Q13442814 @default.
• Q92182785 P356 "10.1016/S1470-2045(19)30388-2" @default.
• Q92182785 P433 "9" @default.
• Q92182785 P478 "20" @default.

• next